ARS Pharmaceuticals, Inc.

Direct answer

ARS Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker SPRY.

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal...

Can you invest in ARS Pharmaceuticals, Inc.?

Yes. ARS Pharmaceuticals, Inc. trades publicly on NASDAQ as SPRY.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for ARS Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.